Introduction
Dear Sir, In sub-Saharan Africa, only South Africa has had a long-standing national hemovigilance system to monitor acute transfusion reactions (Nel and Heyns, 2000) . To improve monitoring, recognition, and reporting of acute transfusion reactions (ATR) more countries in the region have implemented or are considering national hemovigilance systems (Dahourou, Tapko et al., 2012) . In Namibia, The Blood Transfusion Service of Namibia (NAMBTS) is the only organization authorized to collect, process, and distribute blood and blood components for transfusion. Since 2006, NAMBTS has invested heavily in the development of guidelines and training for doctors and nurses in the appropriate clinical use of blood. Coupled with this focus on appropriate use, in 2008 NAMBTS launched a national hemovigilance system with a standardized reporting tool backed by clinical and laboratory investigations of all reported ATR.
Under this system, healthcare workers (HCW) in Namibia who order or perform transfusions (primarily nurses and physicians) are responsible for voluntary reporting of ATR to NAMBTS by phone or via a paper-based system. Reportable ATR include allergic, acute hemolytic, febrile non-hemolytic reactions, sepsis due to bacterial contamination of the donor unit, transfusion associated acute lung injury, transfusion associated circulatory overload, and transfusion as- As observed with other public health surveillance systems, under-reporting can result in inaccurate prevalence and incidence estimates and compromise a system's effectiveness (Alter, Mares et al., 1987) . Identifying the reasons for under-reporting is a priority for blood services developing surveillance systems for ATR. We conducted a survey of HCW in Namibia to ascertain their knowledge about the hemovigilance system; their ability to recognize signs and symptoms of ATR, and; to identify barriers to reporting ATR via the hemovigilance sys- Of all responses, 34% (105/311) were from physicians, 63% (197/311) from nurses, and 3% (9/311) from other cadres. Among respondents, 42% (130/307) reported previously receiving training on clinical management of ATR. Seventy-four percent (74%, 227/307) were aware that a hemovigilance system was available in Namibia, but only 12% (36/309) had previously reported an ATR to NAMBTS. The most common reason for not reporting was "having never seen a reaction." But one third of respondents reported that a patient under their care in Namibia had ever previously experienced an ATR. Nearly three-quarters of all respondents believed there would be no negative personal or professional consequences for reporting an ATR ( Table 1) .
Among all respondents, 96% (298/310) indicated they were capable of identifying an ATR.
However, only 5% (16/311) respondents correctly identified all 15 clinical signs and symptoms of an ATR. The most common correctly identified signs and symptoms were flushing, itching and shortness of breath. The symptoms of ATR that were most commonly not identified by respondents were back pain, unexplained bleeding and red urine.
While these findings provide some clues, they do not provide a clear explanation for the low reporting rate in Namibia, which is likely to be multi-factorial. For example, a large proportion of HCW knew that a hemovigilance system existed, and approximately 40% reported receiving some previous training in the clinical management of ATR. However, while the vast majority of respondents, including doctors and nurses, were confident they could recognize an ATR, only a small minority correctly identified all 15 common signs and symptoms in a test question included in the survey. Given previous observations that transfusion-related education and knowledge is deficient in sub-Saharan Africa, these findings underscore the impor- Some reasons cited by HCW for not reporting included excessive effort required to report and a perception that reactions with minor clinical severity did not merit a report. To mitigate these factors, the reporting process could be simplified or the requirements modified such that only moderate and severe reactions are reportable. Expanding reporting responsibilities to laboratory staff and others outside the clinical wards, may contribute to increased use of the system. Previous reports have documented low reporting of other adverse events among HCW in Africa due to fear of stigma or negative consequences (Bukirwa, Nayiga et al., 2008) .
None of the respondents in our study cited fear of repercussions as a reason for not reporting an acute transfusion reaction, and nearly three-fourths felt that no one would suffer negative consequences by reporting to the system. This suggests an important cultural change around a major perceived barrier (stigma) to the use of the hemovigilance system in Namibia -and potentially elsewhere in sub-Saharan Africa. (Dhingra, 2002; Courbil, Fabrigli et al., 2007) . These include providing access to distance learning materials, implementation of self-directed learning tools as part of training, post-training assessments, and auditing of blood transfusion practices in hospitals.
As blood services across the region continue to develop and gain recognition as an integral part of primary healthcare systems, implementing hemovigilance programs with an emphasis on patient monitoring and adverse event reporting, should be a priority. The success of these programs will rely on governmental and external organizations prioritizing the integration of hemovigilance systems into comprehensive transfusion training programs, implementing policies to identify more efficient ways to focus reporting requirements, and including both clinical and non-clinical staff in the reporting process.
